Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Finding Study in Patients With Mild to Moderate Persistent Asthma: A Parallel Group, Randomised, Placebo Controlled, Double Blind Assessment of Oral Oc000459 Dosed At Three Dose Schedules for Twelve Weeks Finding Study In Patients With Mild To Moderate Persistent Asthma

NCT00890877 is registered in ClinicalTrials.gov with Oxagen Ltd as lead sponsor.

NCT NCT00890877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00890877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Finding Study in Patients With Mild to Moderate Persistent Asthma: A Parallel Group, Randomised, Placebo Controlled, Double Blind Assessment of Oral Oc000459 Dosed At Three Dose Schedules for Twelve Weeks Finding Study In Patients With Mild To Moderate Persistent Asthma
Lead sponsor
Oxagen Ltd
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2009
Completion date
July 31, 2010
Enrollment
480 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

mild to moderate persistent asthma